ADHD Med Increases Kids' CV Risk Later
the Psychiatry Advisor take:
Children and adolescents with attention-deficit/hyperactivity disorder (ADHD) that take methylphenidate-based medications to treat the condition have an elevated — though still very small — risk of developing heart problems later on.
Søren Dalsgaard, MD, of the National Center for Register-based Research at Aarhus University, Denmark, and colleagues examined data from 714,000 children born between 1990 and 1999 and found that the risk of developing cardiovascular (CV) problems was twice as high for those on a drug containing methylphenidate, which is sold under brand names including Concerta and Ritalin.
However, the risk of having a CV adverse event was just 1% in those treated with the drug, compared to approximately 0.5% in the group not on the medication, the researchers reported in the Journal of Child and Adolescent Psychopharmacology.
“I was surprised that the increased risk of heart problems was so high and that the risk did not only apply to children, who were already susceptible to heart ailments,” Dalsgaard said, according to ScienceNordic.com. “The result is worrying. It shows that clinicians must continue to be aware of the risk of heart ailments, when we prescribe medicine to ADHD patients.”
Results also showed that when a dose of methylphenidate was lowered during treatment, the risk of heart problems grew.
Common ADHD Drugs Slightly Increase CV Risk Later on For Children
The risk of developing heart problems was double for children taking methylphenidate for attention-deficit/hyperactivity disorder (ADHD) compared with children not prescribed the medicine.
The study builds on data from 714,000 children born in 1990-1999. It is the most comprehensive, data-based study within the field explains the head of the project Søren Dalsgaard, a psychiatrist at the National Center for Register-based Research at Aarhus University in Denmark.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Age of Onset of Bipolar Disorder Linked With Substance Use Disorders
- Mind-Body Therapy and Psychiatry: Ancient Tools for Modern Practice
- Marijuana Use Associated With Poorer Depression Outcomes, Increased Suicidal Ideation
- Short Forms of Parent General Behavior Inventory Reliable at Identifying Youth Mood Symptoms
- Low Testosterone Linked With Social Anxiety in Boys With Klinefelter Syndrome
- The Psychology of Hoarding Disorder: Approaches for Treatment
- Smartphone Applications for Depression and Anxiety: Are They Ready for Widespread Use?
- The Many Misconceptions of Catatonia: Treatment Is Often Successful With the Right Knowledge
- Digital Media Engagement Associated With ADHD Symptoms in Adolescents
- Strong Social Networks May Mitigate the Effects of Childhood Adversity
- Unexpected Effect of Substance Use Disorders on Recovery From Bipolar Depression
- Republican Opposition to Obamacare: What's Done, What's to Come
- Early Childhood Out-of-Home Placement Associated With Adverse Outcomes in Adulthood
- Opioid Use Disorder Prevalence at Delivery on the Rise in the US, According to CDC
- Integrating Treatments for Opioid Use Disorder and Infectious Diseases